Prevention of cardiovascular disease in patients with rheumatic joint diseases
- Prosjektnummer
- 2013064
- Ansvarlig person
- Anne Grete Semb
- Institusjon
- Diakonhjemmet Sykehus AS
- Prosjektkategori
- Forskerstipend
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 3. Prevention
Nei
Nei
Nie
Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.
Rheumatology (Oxford) 2020 12 01;59(12):3700-3708.
PMID: 32386421
How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study.
Int J Qual Stud Health Well-being 2020 Dec;15(1):1725997.
PMID: 32046611
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.
Rheumatology (Oxford) 2020 08 01;59(8):1997-2004.
PMID: 31782789
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities.
RMD Open 2020 07;6(2).
PMID: 32683326
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.
Nat Rev Rheumatol 2020 07;16(7):361-379. Epub 2020 jun 3
PMID: 32494054
Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models.
Arthritis Res Ther 2020 04 23;22(1):90. Epub 2020 apr 23
PMID: 32326974
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
Eur Heart J Cardiovasc Pharmacother 2020 04 01;6(2):86-93.
PMID: 31392312
Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.
Rheumatol Int 2020 Apr;40(4):523-527. Epub 2020 feb 22
PMID: 32088752
Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases.
PLoS One 2019;14(12):e0226479. Epub 2019 des 12
PMID: 31830762
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
Eur Heart J 2019 Sep 21;40(36):3010-3012.
PMID: 31541549
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.
Cochrane Database Syst Rev 2019 09 02;9():CD012958. Epub 2019 sep 2
PMID: 31476270
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro
Ann Rheum Dis 2020 09;79(9):e105. Epub 2019 aug 14
PMID: 31413003
Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.
BMC Rheumatol 2019;3():33. Epub 2019 aug 8
PMID: 31410391
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
Eur Heart J Cardiovasc Pharmacother 2019 Jul 01;5(3):171-180.
PMID: 31119266
Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis.
Arthritis Care Res (Hoboken) 2019 Sep;71(9):1276-1283. Epub 2019 aug 7
PMID: 30242984
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.
Int J Cardiol 2019 Jan 01;274():311-318. Epub 2018 jul 2
PMID: 30007486
Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project.
RMD Open 2018;4(2):e000737. Epub 2018 okt 1
PMID: 30305931
The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease.
Food Nutr Res 2018;62(). Epub 2018 sep 4
PMID: 30202399
Associations Between Cardiorespiratory Fitness and Arterial Stiffness in Ankylosing Spondylitis: A Cross-sectional Study.
J Rheumatol 2018 Nov;45(11):1522-1525. Epub 2018 jul 1
PMID: 29961684
Optimization of CVD prevention in psoriatic arthritis.
Nat Rev Rheumatol 2018 Jun;14(6):323-324.
PMID: 29686327
Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases.
Int J Cardiol 2018 Feb 01;252():201-206.
PMID: 29249429
The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.
Trials 2017 Nov 28;18(1):570. Epub 2017 nov 28
PMID: 29183347
Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases.
RMD Open 2017;3(2):e000544. Epub 2017 sep 17
PMID: 28955501
Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.
RMD Open 2017;3(1):e000413. Epub 2017 jul 13
PMID: 28955483
Cardiovascular disease risk profiles in inflammatory joint disease entities.
Arthritis Res Ther 2017 Jul 03;19(1):153. Epub 2017 jul 3
PMID: 28673314
Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
PLoS One 2017;12(4):e0175605. Epub 2017 apr 7
PMID: 28388688
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Rheumatology (Oxford) 2017 07 01;56(7):1102-1110.
PMID: 28339992
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Ann Rheum Dis 2017 Jan;76(1):17-28. Epub 2016 okt 3
PMID: 27697765
Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.
Ann Rheum Dis 2017 Feb;76(2):371-376. Epub 2016 jun 7
PMID: 27269296
Response to: 'Disease activity and left ventricular systolic function in rheumatoid arthritis' by Giollo et al.
Ann Rheum Dis 2016 Dec;75(12):e84. Epub 2016 okt 14
PMID: 27742659
Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.
Int J Cardiol 2016 Nov 15;223():331-336. Epub 2016 aug 7
PMID: 27543704
Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.
Nat Rev Rheumatol 2016 Aug;12(8):441-2. Epub 2016 jun 30
PMID: 27357255
Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
J Rheumatol 2016 Sep;43(9):1622-30. Epub 2016 jun 15
PMID: 27307523
The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis.
Blood Press 2016 10;25(5):298-304. Epub 2016 apr 28
PMID: 27123584
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.
PLoS One 2016;11(4):e0153440. Epub 2016 apr 19
PMID: 27093159
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculator.
Rheumatology (Oxford) 2016 Aug;55(8):1528-9. Epub 2016 feb 8
PMID: 26857077
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study.
J Rheumatol 2015 Apr;42(4):645-53. Epub 2015 feb 1
PMID: 25641897
Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
Ann Rheum Dis 2015 Feb 17. Epub 2015 feb 17
PMID: 25691119
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study.
Scand J Rheumatol 2015;44(2):118-24.
PMID: 25756521
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Arthritis Rheumatol 2015 Jul;67(7):1718-28.
PMID: 25778850
CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.
Ann Rheum Dis 2015 Aug;74(8):1562-6. Epub 2015 mar 20
PMID: 25795906
On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.
Ann Rheum Dis 2016 May;75(5):819-24. Epub 2015 mar 26
PMID: 25814652
EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic.
Biomed Res Int 2015;2015():515280. Epub 2015 mar 1
PMID: 25815322
Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management.
Biomed Res Int 2015;2015():850671. Epub 2015 mar 12
PMID: 25861648
The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
PLoS One 2015;10(6):e0130709. Epub 2015 jun 26
PMID: 26114946
Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.
J Rheumatol 2015 Sep;42(9):1548-55. Epub 2015 jul 15
PMID: 26178275
Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.
Arthritis Res Ther 2015;17():279. Epub 2015 okt 8
PMID: 26445924
Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases.
Front Med (Lausanne) 2015;2():80. Epub 2015 nov 10
PMID: 26618159
Serum samples that have been stored long-term (>10 years) can be used as a suitable data source for developing cardiovascular risk prediction models in large observational rheumatoid arthritis cohorts.
Biomed Res Int 2014;2014():930925. Epub 2014 sep 11
PMID: 25295280
Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study.
PLoS One 2014;9(9):e108688. Epub 2014 sep 30
PMID: 25268365
Disease activity and left ventricular structure in patients with rheumatoid arthritis.
Rheumatology (Oxford) 2015 Mar;54(3):511-9. Epub 2014 sep 14
PMID: 25224414
Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study.
Semin Arthritis Rheum 2014 Dec;44(3):309-13. Epub 2014 mai 20
PMID: 24968705
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
Rheumatology (Oxford) 2014 Dec;53(12):2143-54. Epub 2014 jun 6
PMID: 24907149
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.
Ann Rheum Dis 2015 Aug;74(8):1544-50. Epub 2014 apr 3
PMID: 24699940
Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice.
Ann Rheum Dis 2014 Jul;73(7):1284-8. Epub 2014 mar 7
PMID: 24608403
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
Ann Rheum Dis 2014 Jan 3. Epub 2014 jan 3
PMID: 24389293
Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?
Ann Rheum Dis 2013 Nov 1;72(11):1743-6. Epub 2013 aug 9
PMID: 23933626
Hand, hip and knee osteoarthritis in a Norwegian population-based study--the MUST protocol.
BMC Musculoskelet Disord 2013;14():201. Epub 2013 jul 5
PMID: 23826721
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis.
PLoS One 2013;8(4):e60970. Epub 2013 apr 17
PMID: 23613766
Carotid plaque characteristics and disease activity in rheumatoid arthritis.
J Rheumatol 2013 Apr;40(4):359-68. Epub 2013 jan 15
PMID: 23322468
Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative study.
Arthritis Care Res (Hoboken) 2013 Jun;65(6):969-76.
PMID: 23281265
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
Ann Rheum Dis 2013 Dec;72(12):1968-74. Epub 2012 des 22
PMID: 23264359
Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis
Springer International Publishing Switzerland. ISBN 978-3-319-26780-7, ISBN 978-3-319-26782-1 (eBook), DOI 10.1007/978-3-319-26782-1, http://www.springer.com/gb/book/9783319267807
Effekten av kolesterolvennlig kostholdsråd på endring i kosthold og kardiovaskulære risikofaktorer hos pasienter med leddsykdom
Ernæringsfysiologisk mastergrad, Ernæringsfysilogisk Institutt, Universitet i Oslo, November 2016 Hovedveileder: AG Semb, Biveiledere: S Rollefstad, SU Olsen, K Holven
Intensive lipid lowering treatment in patients with inflammatory joint diseases.
Chapter 26 in Handbook of lipids in human function.Elsevier Science and Technology books 2015 (in press)
Carotid artery atherosclerosis in patients with inflammatory joint diseases: Risk factors, prognosis and management.
Chapter in book: Carotid Artery Disease: Risk factors, Prognosis and management. Nova Science Publishers 2015 (in press)
A Handbook of cardiovascular disease management in Rheumatoid Arthritis
Springer Verlag (in press)
Cardiovascular Disease Risk Evaluation
Chapter 4.1 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Cardiovascular Disease Risk Calculators
Chapter 4.2 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Pringer Verlag, (in press)
Cardiovascular prevention
Chapter 4.3 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Exploring therapeutic targets
Chapter 7.1 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
New medications to treat both indications
Chapter 7.2 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Future outlook and overarching goals
Chaper 7.3 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Chronic kidney disease reduces risk of CVD in patients with RA according to the QRISK lifetime cardiovascular risk calculator
Rheumatology doi:10.1093/rheumatology/kew002
Non-Pharmacological Interventions for Cardiovascular Complications in Patients With Rheumatoid Arthritis
Chapter 6.1 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Smoking
Chapter 6.2 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Weight control and Body Composition.
Chapter 6.3 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Diet and nutrition
Chapter 6.4 in A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis.
Chapter 5 A Handbook of cardiovascular disease management in Rheumatoid Arthritis, Springer Verlag (in press)
RA and Carotid Plaques: Five Things to Know
http://www.musculoskeletalnetwork.com/rheumatoid-arthritis/content/article/1145622/2127227
Leddsykdom og forebygging av hjerte- og karsykdom
Revmatikeren, 2013
Smoking cessation among people with rheumatoid arthritis
- Disputert:
- januar 2020
- Hovedveileder:
- Bente Appel Esbensen
Coronary CT angiography in the assesssment of coronary artery disease in high-risk populations
- Disputert:
- juni 2017
- Hovedveileder:
- Ingrid Ylva Natasha Haig
Cardiovascular disease risk in inflammatory joint disease
- Disputert:
- februar 2019
- Hovedveileder:
- Anne Grete Semb
Cardiovascular Disease and osteoporosis i psoriatic arthritis
- Disputert:
- april 2018
- Hovedveileder:
- Mari Hoff
Markers of Progression and Regression of Atherosclerotic Cardiovascular Disease in Patients with Inflammatory Joint Diseases
- Disputert:
- juni 2017
- Hovedveileder:
- Anne Grete Semb
The Complexities of Accurately Assessing Cardiovascular Disease Risk among Patients with Rheumatoid Arthritis
- Disputert:
- desember 2017
- Hovedveileder:
- Anne Grete Semb
Subclinical cardiovascular disease in patients with RA
- Disputert:
- januar 2016
- Hovedveileder:
- Eva Gerdts, biveileder: AG Semb
Ankylosing Spondylitis and atherosclerotic cardiovascular disease
- Disputert:
- januar 2016
- Hovedveileder:
- Sella Provan, biveileder: AG Semb
Novel results from cardiovascular prevention in patinets with inflammatory joint diseases
- Disputert:
- februar 2015
- Hovedveileder:
- Anne Grete Semb
- Ellen-Margrethe Hauge Forsker (annen finansiering)
- George Karpouzas Forsker (annen finansiering)
- Elena Myasoedova Forsker (annen finansiering)
- Joe Sexton Forsker (annen finansiering)
- Jonny Hisdal Forsker (annen finansiering)
- Olav Øverland Brukerrepresentant
- Thalita Blanck Brukerrepresentant
- Sella Aarrestad Provan Postdoktorstipendiat (annen finansiering)
- Inger Jorid Berg Forsker (annen finansiering)
- Ian Graham Forsker (annen finansiering)
- Cynthia Sue Crowson Doktorgradsstipendiat (annen finansiering)
- Piet van Riel Forsker (annen finansiering)
- Sherine Gabriel Forsker (annen finansiering)
- George Kitas Forsker (annen finansiering)
- Arthur Kavanaugh Forsker (annen finansiering)
- Inge Christoffer Olsen Prosjektdeltaker
- Bente Appel Esbensen Hovedveileder
- Mikkel Østergård Forsker (annen finansiering)
- Ida Roelsgaard Doktorgradsstipendiat (annen finansiering)
- Sissel Urke Olsen Doktorgradsstipendiat (annen finansiering)
- Maria Grorud Fagerhøi Prosjektdeltaker
- Mari Hoff Postdoktorstipendiat (annen finansiering)
- Agnete Malm Gulati Doktorgradsstipendiat (annen finansiering)
- Hanne Solveig Dagfinrud Forskningsgruppeleder
- Nina Østerås Forsker (annen finansiering)
- Helga Bergljot Midtbø Forsker (annen finansiering)
- Eva Gerdts Forsker (annen finansiering)
- Ingrid Ylva Natasha Haig Hovedveileder
- Nils Einar Kløw Forsker (annen finansiering)
- Tore Kristian Kvien Forsker (annen finansiering)
- Glenn Haugeberg Medveileder
- Tillmann Uhlig Prosjektleder
- Hilde Berner Hammer Forsker (annen finansiering)
- Silje Halvorsen Sveaas Forsker (annen finansiering)
- Mona Svanteson Doktorgradsstipendiat (annen finansiering)
- Grunde Wibetoe Doktorgradsstipendiat (annen finansiering)
- Eirik Ikdahl Doktorgradsstipendiat (annen finansiering)
- Silvia Christin Hellerud Rollefstad Postdoktorstipendiat (annen finansiering)
- Anne Grete Semb Forskningsgruppeleder
- Cynthia Crowson Forsker (annen finansiering)
- Ylva Haig Postdoktorstipendiat (annen finansiering)
- Hanne Sofie Dagfinrud Forskningsgruppeleder
- Ida Kristin Haugen Postdoktorstipendiat
- Espen Andre Haavardsholm Forsker (annen finansiering)
- Elke Arts Doktorgradsstipendiat
- Ingar Holme Forsker (annen finansiering)
- Inge Christoffer Olse Forsker (annen finansiering)
- Helga Midtbø Doktorgradsstipendiat
- Tore K. Kvien Biveileder
- Silvia Rollefstad Doktorgradsstipendiat
- Terje Rolf Pedersen Biveileder
- Hanne S Dagfinrud Forskningsgruppeleder
- Ingvild Eeg Prosjektdeltaker
- Per Kristian Hol Forsker (annen finansiering)
- Marthe Thoresen Mæhlen Doktorgradsstipendiat
- Silvia Rollefsatd Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport